No Data
No Data
Clarity Pharmaceuticals Target Price Raised 97% to A$6.10/Share by Jefferies>CU6.AU
Clarity Pharmaceuticals Target Price Raised 97% to A$6.10/Share by Jefferies>CU6.
3 ASX Small-cap Shares That Soared 250% to 675% in FY24
The S&P/ASX All Ordinaries Index (ASX: XAO) moved 8.27% higher in FY24, which is a perfectly respectable return.
5 ASX All Ords Shares That Rose 250% to 700% in FY24
While past performance is never a guarantee of future performance, let's take a look at some of the ASX All Ords shares that went gangbusters in FY24, delivering some mesmerising share price gains.
Clarity Pharmaceuticals Receives AU$10 Million R&D Tax Refund
Clarity Pharmaceuticals (ASX:CU6) received about AU$10 million in research and development refund as part of the Australian government's tax incentive program, according to a Monday filing with the Au
Why Clarity Pharmaceuticals, Life360, Ramsay Health Care, and Spartan Resources Shares Are Rising Today
The S&P/ASX 200 Index (ASX: XJO) is having a subdued session on Tuesday and is trading slightly lower. In afternoon trade, the benchmark index is down 0.1% to 7,754.1 points.
Is Clarity Pharmaceuticals Ltd (ASX:CU6) Trading At A 48% Discount?
No Data